The effects of insulin on the endothelium

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue SUPPL. 2, 2007, Pages 20-26

  Fonseca, Vivian A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK REDUCTION;

BLOOD VESSELS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN; MODELS, BIOLOGICAL; MORBIDITY; OXIDATIVE STRESS; VASCULITIS;

EID: 41749112679     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(07)80009-0     Document Type: Article

References (30)

1. Dagenais G., Ahmed Z., Robitaille N., et al. Total and coronary heart disease mortality in relation to major risk factors-Quebec Cardiovascular Study. Can J Cardiol 6 (1990) 59-65
2. Pyorala M., Miettinen H., Laakso M., et al. Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 23 (2000) 1097-1102
3. Nathan D., Cleary P., Backlund J., et al. for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [published correction appears in Lancet 1998;352:1558]. Lancet 352 (1998) 854-865
6. Dandona P., Aljada A., and Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45 (2002) 924-930
7. Nathan D., Lachin J., Cleary P., et al. for the Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348 (2003) 2294-2303
8. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314 (1997) 1512-1515 for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group
9. Malmberg K., Ryden L., Wedel H., et al. for the DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
10. Mehta S., Yusuf S., Diaz R., et al. for the CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
11. Baron A. Insulin and the vasculature-old actors, new roles. J Investig Med 44 (1996) 406-412
12. Baron A. Hemodynamic actions of insulin. Am J Physiol 267 (1994) E187-E202
13. Srinivasan M., Herrero P., McGill J., et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46 (2005) 42-48
14. Zeng G., and Quon M. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98 (1996) 894-898
15. Aljada A., and Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49 (2000) 147-150
16. Feener E., and King G. Vascular dysfunction in diabetes mellitus. Lancet 350 Suppl 1 (1997) S13-S19
17. Dandona P. Endothelium, inflammation, and diabetes. Curr Diab Rep 2 (2002) 311-315
18. Feng L., Matsumoto C., Schwartz A., et al. Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care 28 (2005) 379-384
19. Libby P., Ridker P., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
20. Festa A., D'Agostino Jr. R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
21. Barnes P., and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
22. Aljada A., Ghanim H., Saadeh R., et al. Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 86 (2001) 450-453
23. Aljada A., Ghanim H., Mohanty P., et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87 (2002) 1419-1422
24. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 86 (2001) 3257-3265
25. Stentz F., Umpierrez G., Cuervo R., et al. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53 (2004) 2079-2086
26. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
27. Fonseca V., Theuma P., Mudaliar S., et al. Diabetes treatments have differential effects on nontraditional cardiovascular risk factors. J Diabetes Complications 20 (2006) 14-20
28. Hansen T., Thiel S., Wouters P., et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88 (2003) 1082-1088
29. Albertini J., Valensi P., Lormeau B., et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21 (1998) 1008-1013
30. Chaudhuri A., Janicke D., Wilson M., et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109 (2004) 849-854